Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $5.91 which represents a slight increase of $0.15 or 2.60% from the prior close of $5.76. The stock opened at $5.9 and ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

In a report released today, Paul Newsome from Piper Sandler assigned a Hold rating to Travelers Companies (TRV – Research Report), with a price ...